Profile/Targets
"Association for Immunotherapy of Cancer"
www.c-imt.org / www.cancerimmunotherapy.org
The Association
The "Association for Immunotherapy of Cancer" was founded in fall 2002 as an information and education platform for immunological cancer therapy. Physicians and researchers from different fields of clinical and theoretical medicine from the universities of Berlin, Erlangen, Mainz and Tübingen are the initiators of the association. A schematic overview of the organization, targets and the Association's network with other related activities is illustrated below:
Organisation & Financing
The non-profit Association for Immunotherapy of Cancer is located at the Tumor Vaccination Center of the Johannes Gutenberg-University Mainz, established in 1999 with the support of the "Deutsche Krebshilfe" (German Cancer Aid). The association is financed by donations, congress fees and pharma-sponsoring. The "Deutsche Krebshilfe" holds the patronage over the association's congress events and public relations.
The managing committee of the association are:
Targets
The target of the Association for Immunotherapy of Cancer is to establish an information and education network by three complementary measures:
Network
The Association for Immunotherapy of Cancer's network is established in different fields of medical activity, thus it tends automatically to become an interdisciplinary co-operation. The interdisciplinary tendency of the association is also supported by the structure of its scientific advisory board where the following professional groups are represented:
www.c-imt.org / www.cancerimmunotherapy.org
The Association
The "Association for Immunotherapy of Cancer" was founded in fall 2002 as an information and education platform for immunological cancer therapy. Physicians and researchers from different fields of clinical and theoretical medicine from the universities of Berlin, Erlangen, Mainz and Tübingen are the initiators of the association. A schematic overview of the organization, targets and the Association's network with other related activities is illustrated below:
Organisation & Financing
The non-profit Association for Immunotherapy of Cancer is located at the Tumor Vaccination Center of the Johannes Gutenberg-University Mainz, established in 1999 with the support of the "Deutsche Krebshilfe" (German Cancer Aid). The association is financed by donations, congress fees and pharma-sponsoring. The "Deutsche Krebshilfe" holds the patronage over the association's congress events and public relations.
The managing committee of the association are:
|
Prof. Dr. Hämmerling Deutsches Krebsforschungszentrum Im Neuenheimer Feld 280 69120 Heidelberg Prof. Dr. Huber IIIrd Department of Internal Medicine Johannes Gutenberg-University Langenbeckstr. 1 55101 Mainz Prof. Dr. Rammensee Institute of Cell Biology Department of Immunology Auf der Morgenstelle 15 72076 Tübingen Prof. Dr. Schuler Dermatological University Hospital Hartmannstr. 14 91054 Erlangen Prof. Dr. Walden Department of Dermatology Campus Charité Mitte 10098 Berlin |
Tumor Vaccination Center at the
Johannes Gutenberg-University Mainz |
Targets
The target of the Association for Immunotherapy of Cancer is to establish an information and education network by three complementary measures:
- By the creation of a web database "Clinical Trials", for physicians and interestedpublic. This site will provide the following information for both groups of interest:
- a comprehensive overview of the targets and specific characteristics of the clinical cancer immunotherapy trials running in Germany and in other European countries
- support establishing contact with the respective investigators of clinical trials.
- By holding annual meetings on interdisciplinary cancer immunotherapy. These meetings should present an update on the basics and clinical application aspects of immunological cancer therapies at least once a year.
- By organizing interdisciplinary postgraduate courses for physicians and scientists in laboratories and hospitals with special attention to the regulatory aspects of immune cancer therapy trials. During the course of the training program the participants will participate in theoretical and practical training according to a structured curriculum at each of the four university locations.
Network
The Association for Immunotherapy of Cancer's network is established in different fields of medical activity, thus it tends automatically to become an interdisciplinary co-operation. The interdisciplinary tendency of the association is also supported by the structure of its scientific advisory board where the following professional groups are represented:
-
German Society of Immunology (Die Deutsche Gesellschaft für Immunologie, DGfI) represented by Prof. Blankenstein, Berlin
-
German Society of Hematology and Oncology (Die Deutsche Gesellschaft für Hämatologie und Onkologie) represented by Prof. Dörken, Berlin
-
German Society of Gynecology (Die Deutsche Gesellschaft für Gynäkologie) represented by Prof. Wagner, Marburg
-
Work group for internal Oncology (Die AG für Internistische Onkologie) represented by Prof. Keilholz, Berlin
-
Work Group for Oncology of the German Society for Digestional and Metabolical Diseases (Die AG für Onkologie der Deutschen Gesellschaft für Verdauungs- und Stoffwechsel-krankheiten) represented by Prof. Schmiegel, Bochum
-
German Society of Dermatology (Die Deutsche Dermatologische Gesellschaft) represented by Prof. Sterry, Berlin
-
German Society of Urology (Deutsche Gesellschaft für Urologie) represented by Prof. Jocham, Lübeck.
